1.Bioscience and Biomedical Engineering Thrust, the Hong Kong University of Science and Technology (Guangzhou), Guangzhou 511400, China
2.Department of Nephrology, Center of Kidney and Urology, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, Guangdong, China
3.Division of Life Science, the Hong Kong University of Science and Technology, Hong Kong 999077, China
Author bio:
*junwuhkust@ust.hk
Funds:
the National Natural Science Foundation of China(52173150);the Guangzhou Science and Technology Program City-University Joint Funding Project(2023A03J0001);the Postdoctoral Fellowship Program of CPSF(GZC20233297)
In situ genetic engineering of host T-cells based on acellular scaffold strategy: a big but also small step for solid tumor immunotherapy[J]. MMR, 2025,12(4):636-638.
Cite this article as: Han SY, Zhao ZX, Wu J. In situ genetic engineering of host T-cells based on acellular scaffold strategy: a big but also small step for solid tumor immunotherapy. Mil Med Res. 2024;11(1):12.
In situ genetic engineering of host T-cells based on acellular scaffold strategy: a big but also small step for solid tumor immunotherapy[J]. MMR, 2025,12(4):636-638. DOI: 10.1186/s40779-024-00517-8.
Cite this article as: Han SY, Zhao ZX, Wu J. In situ genetic engineering of host T-cells based on acellular scaffold strategy: a big but also small step for solid tumor immunotherapy. Mil Med Res. 2024;11(1):12. DOI: 10.1186/s40779-024-00517-8.
In situ genetic engineering of host T-cells based on acellular scaffold strategy: a big but also small step for solid tumor immunotherapy